Curis
CRIS
#11060
Rank
NZ$8.22 M
Marketcap
NZ$0.86
Share price
1.20%
Change (1 day)
-57.04%
Change (1 year)

Earnings for Curis (CRIS)

Earnings in 2026 (TTM): -NZ$15.06 Million

According to Curis's latest financial reports the company's current earnings are NZ$4.31 Million. In 2025 the company made an earning of -NZ$9.83 Million, an increase over its 2024 earnings that were of -NZ$77.85 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Curis from 2001 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$15.06 Million53.25%
2025 -NZ$9.83 Million-87.38%
2024 -NZ$77.85 Million-5.77%
2023 -NZ$82.61 Million-13.1%
2022 -NZ$95.06 Million27.52%
2021 -NZ$74.55 Million65.09%
2020 -NZ$45.16 Million-9.1%
2019 -NZ$49.68 Million-4.73%
2018 -NZ$52.14 Million-41.95%
2017 -NZ$89.81 Million-14.37%
2016 -NZ$0.11 Billion3.55%
2015 -NZ$0.11 Billion271.52%
2014 -NZ$27.27 Million76.64%
2013 -NZ$15.44 Million
2011 -NZ$13.11 Million27.76%
2010 -NZ$10.26 Million-43.87%
2009 -NZ$18.28 Million-23.44%
2008 -NZ$23.88 Million56.66%
2007 -NZ$15.25 Million-16.71%
2006 -NZ$18.3 Million-36.92%
2005 -NZ$29.01 Million156.25%
2004 -NZ$11.32 Million-37.24%
2003 -NZ$18.04 Million-93.34%
2002 -NZ$0.28 Billion86.79%
2001 -NZ$0.15 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
NZ$12.68 B-82,581.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$20.62 B-134,238.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-NZ$0.12 Billion 632.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
NZ$1.93 B-12,716.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-NZ$0.6 Billion 3,756.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-NZ$40.51 Million 163.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
-NZ$0.36 Billion 2,203.50%๐Ÿ‡บ๐Ÿ‡ธ USA